A number of investment brokers have recently updated their price targets on shares of Ampio Pharmaceuticals, Inc. (AMPE).

Most recent broker ratings

08/22/2014 – Ampio Pharmaceuticals, Inc. was downgraded to “hold” by analysts at Jefferies. They now have a USD 5 price target on the stock.

08/21/2014 – Ampio Pharmaceuticals, Inc. had its “buy” rating reiterated by analysts at Aegis Capital.

05/08/2014 – Citigroup began new coverage on Ampio Pharmaceuticals, Inc. giving the company a “buy” rating. They now have a USD 21 price target on the stock.

The share price of Ampio Pharmaceuticals, Inc. (AMPE) was down -1.04% during the last trading session, with a day high of 3.88. 276006 shares were traded on Ampio Pharmaceuticals, Inc.’s last session.

The stock’s 50 day moving average is 3.27 and its 200 day moving average is 2.93. The stock’s market capitalization is 197.59M. Ampio Pharmaceuticals, Inc. has a 52-week low of 1.69 and a 52-week high of 4.32.

View other investors thoughts on Ampio Pharmaceuticals, Inc. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.